Carcinogenic Effects of Immunosuppressive Drugs in Man View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1991

AUTHORS

D. Schmähl , B. Bunk

ABSTRACT

There is hardly any other field in chemical carcinogenesis in which such good agreement between experimental and clinical results has been reached as in carcinogenesis induced by antineoplastic agents. As early as 1967, the carcinogenic effects of the two alkylating drugs cyclophosphamide and triazichone in rats were reported (Schmähl 1967). The results were systematically supported in later experiments and extended to other antineoplastic compounds (Schmähl and Osswald 1970). The investigations revealed that predominantly those antineoplastic drugs which have an alkylating mechanism of action had to be classified as potential carcinogens, whereas antimetabolites and antimitotics exerted practically no carcinogenic effects. The doses required to induce cancer in rats and mice corresponded to doses administered to patients on a mg/kg basis. The findings obtained in 1970 were later on confirmed in numerous investigations carried out in other laboratories (see review in Schmähl and Kaldor 1986). Experiments on the mechanism of the carcinogenic action of alkylating agents yielded the clear result that this type of carcinogenesis is not linked to the immunosuppressive porperties of alkylating agents, but is due to direct interaction between the alkylating agent and DNA. More... »

PAGES

127-131

Book

TITLE

Cancer in Organ Transplant Recipients

ISBN

978-3-540-53020-6
978-3-642-75991-8

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-75991-8_12

DOI

http://dx.doi.org/10.1007/978-3-642-75991-8_12

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044177854


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Schm\u00e4hl", 
        "givenName": "D.", 
        "id": "sg:person.0105462430.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Bunk", 
        "givenName": "B.", 
        "id": "sg:person.01060044550.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060044550.47"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1991", 
    "datePublishedReg": "1991-01-01", 
    "description": "There is hardly any other field in chemical carcinogenesis in which such good agreement between experimental and clinical results has been reached as in carcinogenesis induced by antineoplastic agents. As early as 1967, the carcinogenic effects of the two alkylating drugs cyclophosphamide and triazichone in rats were reported (Schm\u00e4hl 1967). The results were systematically supported in later experiments and extended to other antineoplastic compounds (Schm\u00e4hl and Osswald 1970). The investigations revealed that predominantly those antineoplastic drugs which have an alkylating mechanism of action had to be classified as potential carcinogens, whereas antimetabolites and antimitotics exerted practically no carcinogenic effects. The doses required to induce cancer in rats and mice corresponded to doses administered to patients on a mg/kg basis. The findings obtained in 1970 were later on confirmed in numerous investigations carried out in other laboratories (see review in Schm\u00e4hl and Kaldor 1986). Experiments on the mechanism of the carcinogenic action of alkylating agents yielded the clear result that this type of carcinogenesis is not linked to the immunosuppressive porperties of alkylating agents, but is due to direct interaction between the alkylating agent and DNA.", 
    "editor": [
      {
        "familyName": "Schm\u00e4hl", 
        "givenName": "Dietrich", 
        "type": "Person"
      }, 
      {
        "familyName": "Penn", 
        "givenName": "Israel", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-75991-8_12", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-540-53020-6", 
        "978-3-642-75991-8"
      ], 
      "name": "Cancer in Organ Transplant Recipients", 
      "type": "Book"
    }, 
    "keywords": [
      "carcinogenic effects", 
      "types of carcinogenesis", 
      "immunosuppressive drugs", 
      "clinical results", 
      "antineoplastic agents", 
      "antineoplastic drugs", 
      "drug cyclophosphamide", 
      "carcinogenic action", 
      "chemical carcinogenesis", 
      "carcinogenesis", 
      "antineoplastic compounds", 
      "rats", 
      "doses", 
      "potential carcinogens", 
      "drugs", 
      "agents", 
      "cyclophosphamide", 
      "patients", 
      "cancer", 
      "mice", 
      "antimetabolites", 
      "men", 
      "carcinogens", 
      "numerous investigations", 
      "effect", 
      "direct interaction", 
      "action", 
      "antimitotics", 
      "clear results", 
      "findings", 
      "mechanism", 
      "results", 
      "investigation", 
      "DNA", 
      "laboratory", 
      "later experiments", 
      "types", 
      "compounds", 
      "basis", 
      "interaction", 
      "experiments", 
      "porperties", 
      "agreement", 
      "field", 
      "good agreement", 
      "such good agreement"
    ], 
    "name": "Carcinogenic Effects of Immunosuppressive Drugs in Man", 
    "pagination": "127-131", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044177854"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-75991-8_12"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-75991-8_12", 
      "https://app.dimensions.ai/details/publication/pub.1044177854"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:53", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_436.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-642-75991-8_12"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75991-8_12'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75991-8_12'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75991-8_12'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-75991-8_12'


 

This table displays all metadata directly associated to this object as RDF triples.

112 TRIPLES      22 PREDICATES      71 URIs      64 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-75991-8_12 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author Nc80554c668e64494b5480f84282024f3
4 schema:datePublished 1991
5 schema:datePublishedReg 1991-01-01
6 schema:description There is hardly any other field in chemical carcinogenesis in which such good agreement between experimental and clinical results has been reached as in carcinogenesis induced by antineoplastic agents. As early as 1967, the carcinogenic effects of the two alkylating drugs cyclophosphamide and triazichone in rats were reported (Schmähl 1967). The results were systematically supported in later experiments and extended to other antineoplastic compounds (Schmähl and Osswald 1970). The investigations revealed that predominantly those antineoplastic drugs which have an alkylating mechanism of action had to be classified as potential carcinogens, whereas antimetabolites and antimitotics exerted practically no carcinogenic effects. The doses required to induce cancer in rats and mice corresponded to doses administered to patients on a mg/kg basis. The findings obtained in 1970 were later on confirmed in numerous investigations carried out in other laboratories (see review in Schmähl and Kaldor 1986). Experiments on the mechanism of the carcinogenic action of alkylating agents yielded the clear result that this type of carcinogenesis is not linked to the immunosuppressive porperties of alkylating agents, but is due to direct interaction between the alkylating agent and DNA.
7 schema:editor N9e6d9b29ff8046a9a2c1f79d2c505729
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N95739cb569ec4c31890527e0ef2c5133
11 schema:keywords DNA
12 action
13 agents
14 agreement
15 antimetabolites
16 antimitotics
17 antineoplastic agents
18 antineoplastic compounds
19 antineoplastic drugs
20 basis
21 cancer
22 carcinogenesis
23 carcinogenic action
24 carcinogenic effects
25 carcinogens
26 chemical carcinogenesis
27 clear results
28 clinical results
29 compounds
30 cyclophosphamide
31 direct interaction
32 doses
33 drug cyclophosphamide
34 drugs
35 effect
36 experiments
37 field
38 findings
39 good agreement
40 immunosuppressive drugs
41 interaction
42 investigation
43 laboratory
44 later experiments
45 mechanism
46 men
47 mice
48 numerous investigations
49 patients
50 porperties
51 potential carcinogens
52 rats
53 results
54 such good agreement
55 types
56 types of carcinogenesis
57 schema:name Carcinogenic Effects of Immunosuppressive Drugs in Man
58 schema:pagination 127-131
59 schema:productId N601c9f381d5d4955ba5a73098e9c22d7
60 Ne3750332732d4f71a5728959490e8f8e
61 schema:publisher Na1c615ddc74c41cdae4b98a9107d232d
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044177854
63 https://doi.org/10.1007/978-3-642-75991-8_12
64 schema:sdDatePublished 2022-12-01T06:53
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher N4b9d107e1f5f4cc3a1494ed52e8b7039
67 schema:url https://doi.org/10.1007/978-3-642-75991-8_12
68 sgo:license sg:explorer/license/
69 sgo:sdDataset chapters
70 rdf:type schema:Chapter
71 N439f81920e2c4e2389e2d4146d31c1b0 rdf:first sg:person.01060044550.47
72 rdf:rest rdf:nil
73 N4b9d107e1f5f4cc3a1494ed52e8b7039 schema:name Springer Nature - SN SciGraph project
74 rdf:type schema:Organization
75 N601c9f381d5d4955ba5a73098e9c22d7 schema:name dimensions_id
76 schema:value pub.1044177854
77 rdf:type schema:PropertyValue
78 N746efb0856b948cc8b8b3a964763b556 rdf:first Na421dbabc3104dbf97036ba9087a06a0
79 rdf:rest rdf:nil
80 N95739cb569ec4c31890527e0ef2c5133 schema:isbn 978-3-540-53020-6
81 978-3-642-75991-8
82 schema:name Cancer in Organ Transplant Recipients
83 rdf:type schema:Book
84 N9e6d9b29ff8046a9a2c1f79d2c505729 rdf:first Nda141cb1bcf24eddb780b3a8ad57caa6
85 rdf:rest N746efb0856b948cc8b8b3a964763b556
86 Na1c615ddc74c41cdae4b98a9107d232d schema:name Springer Nature
87 rdf:type schema:Organisation
88 Na421dbabc3104dbf97036ba9087a06a0 schema:familyName Penn
89 schema:givenName Israel
90 rdf:type schema:Person
91 Nc80554c668e64494b5480f84282024f3 rdf:first sg:person.0105462430.55
92 rdf:rest N439f81920e2c4e2389e2d4146d31c1b0
93 Nda141cb1bcf24eddb780b3a8ad57caa6 schema:familyName Schmähl
94 schema:givenName Dietrich
95 rdf:type schema:Person
96 Ne3750332732d4f71a5728959490e8f8e schema:name doi
97 schema:value 10.1007/978-3-642-75991-8_12
98 rdf:type schema:PropertyValue
99 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
100 schema:name Medical and Health Sciences
101 rdf:type schema:DefinedTerm
102 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
103 schema:name Pharmacology and Pharmaceutical Sciences
104 rdf:type schema:DefinedTerm
105 sg:person.0105462430.55 schema:familyName Schmähl
106 schema:givenName D.
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55
108 rdf:type schema:Person
109 sg:person.01060044550.47 schema:familyName Bunk
110 schema:givenName B.
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060044550.47
112 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...